TWM
AMGN icon

Tripletail Wealth Management’s Amgen AMGN Stock Holding History

Tripletail Wealth Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$283K Sell
812
-16
-2% -$5.7K 0.39% 54
2025
Q4 		$271K Sell
828
-22
-3% -$6.98K 0.34% 54
2025
Q3 		$249K Hold
850
– – 0.29% 58
2025
Q2 		$243K Buy
+850
New +$241K 0.35% 60

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Tripletail Wealth Management's AMGN Position: Q1 2026 in Review

Tripletail Wealth Management reduced its Amgen (AMGN) stake by 1.9% in Q1 2026, selling an estimated $5.7K and leaving 812 shares worth $283K. The position accounts for 0.39% of the portfolio, ranked #54.

Tripletail Wealth Management first reported a position in AMGN in Q2 2025 and has held it in 4 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Tripletail Wealth Management held 812 shares of Amgen worth $283K as of Q1 2026.
  • Tripletail Wealth Management sold 16 Amgen shares in Q1 2026, an estimated $5.7K.
  • Amgen made up 0.39% of Tripletail Wealth Management's portfolio in Q1 2026, its #54 holding.
  • Tripletail Wealth Management first reported a position in Amgen in Q2 2025 and has held it in 4 quarters since.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Tripletail Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.